These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Computational models of populations of bacteria and lytic phage. Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960 [TBL] [Abstract][Full Text] [Related]
25. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes? Fernández L; Duarte AC; Rodríguez A; García P Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552 [TBL] [Abstract][Full Text] [Related]
27. Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality? Brüssow H Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):785-788. PubMed ID: 28612636 [No Abstract] [Full Text] [Related]
28. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy. Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610 [TBL] [Abstract][Full Text] [Related]
29. Phage therapy for severe bacterial infections: a narrative review. Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298 [TBL] [Abstract][Full Text] [Related]
30. Naturally-occurring and cultured bacteriophages in human therapy. Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040 [TBL] [Abstract][Full Text] [Related]
31. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Segall AM; Roach DR; Strathdee SA Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502 [TBL] [Abstract][Full Text] [Related]
32. Phage Therapy: The Pharmacology of Antibacterial Viruses. Danis-Wlodarczyk K; Dąbrowska K; Abedon ST Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951 [TBL] [Abstract][Full Text] [Related]
34. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
35. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application? Maciejewska B; Olszak T; Drulis-Kawa Z Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169 [TBL] [Abstract][Full Text] [Related]
37. Virulence-associated factors as targets for phage infection. de Melo AG; Morency C; Moineau S Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419 [TBL] [Abstract][Full Text] [Related]
38. The Diverse Impacts of Phage Morons on Bacterial Fitness and Virulence. Taylor VL; Fitzpatrick AD; Islam Z; Maxwell KL Adv Virus Res; 2019; 103():1-31. PubMed ID: 30635074 [TBL] [Abstract][Full Text] [Related]